124 related articles for article (PubMed ID: 15547750)
1. Loss of imprinting of PEG1/MEST in lung cancer cell lines.
Nakanishi H; Suda T; Katoh M; Watanabe A; Igishi T; Kodani M; Matsumoto S; Nakamoto M; Shigeoka Y; Okabe T; Oshimura M; Shimizu E
Oncol Rep; 2004 Dec; 12(6):1273-8. PubMed ID: 15547750
[TBL] [Abstract][Full Text] [Related]
2. Peg1/Mest in obese adipose tissue is expressed from the paternal allele in an isoform-specific manner.
Kamei Y; Suganami T; Kohda T; Ishino F; Yasuda K; Miura S; Ezaki O; Ogawa Y
FEBS Lett; 2007 Jan; 581(1):91-6. PubMed ID: 17182038
[TBL] [Abstract][Full Text] [Related]
3. Frequent loss of imprinting of PEG1/MEST in invasive breast cancer.
Pedersen IS; Dervan PA; Broderick D; Harrison M; Miller N; Delany E; O'Shea D; Costello P; McGoldrick A; Keating G; Tobin B; Gorey T; McCann A
Cancer Res; 1999 Nov; 59(21):5449-51. PubMed ID: 10554015
[TBL] [Abstract][Full Text] [Related]
4. Imprinting and expression status of isoforms 1 and 2 of PEG1/MEST gene in uterine leiomyoma.
Moon YS; Park SK; Kim HT; Lee TS; Kim JH; Choi YS
Gynecol Obstet Invest; 2010; 70(2):120-5. PubMed ID: 20339302
[TBL] [Abstract][Full Text] [Related]
5. Loss-of-imprinting of Peg1 in mouse interspecies hybrids is correlated with altered growth.
Shi W; Lefebvre L; Yu Y; Otto S; Krella A; Orth A; Fundele R
Genesis; 2004 May; 39(1):65-72. PubMed ID: 15124229
[TBL] [Abstract][Full Text] [Related]
6. Monoallelic expression of human PEG1/MEST is paralleled by parent-specific methylation in fetuses.
Riesewijk AM; Hu L; Schulz U; Tariverdian G; Höglund P; Kere J; Ropers HH; Kalscheuer VM
Genomics; 1997 Jun; 42(2):236-44. PubMed ID: 9192843
[TBL] [Abstract][Full Text] [Related]
7. The novel gene, gamma2-COP (COPG2), in the 7q32 imprinted domain escapes genomic imprinting.
Yamasaki K; Hayashida S; Miura K; Masuzaki H; Ishimaru T; Niikawa N; Kishino T
Genomics; 2000 Sep; 68(3):330-5. PubMed ID: 10995575
[TBL] [Abstract][Full Text] [Related]
8. [Expression of imprinted Igf2 and Peg1/Mest genes in postimplantation parthenogenetic mouse embryos treated with transforming growth factor alpha in vitro].
Penkov LI; Kondrakhina MS; Mironova OV; Platonov ES
Genetika; 2008 Aug; 44(8):1148-52. PubMed ID: 18825967
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the mitochondrial displacement loop in lung cancers.
Suzuki M; Toyooka S; Miyajima K; Iizasa T; Fujisawa T; Bekele NB; Gazdar AF
Clin Cancer Res; 2003 Nov; 9(15):5636-41. PubMed ID: 14654546
[TBL] [Abstract][Full Text] [Related]
10. Genomic imprinting of IGF2, p57(KIP2) and PEG1/MEST in a marsupial, the tammar wallaby.
Suzuki S; Renfree MB; Pask AJ; Shaw G; Kobayashi S; Kohda T; Kaneko-Ishino T; Ishino F
Mech Dev; 2005 Feb; 122(2):213-22. PubMed ID: 15652708
[TBL] [Abstract][Full Text] [Related]
11. Imprinting of PEG1/MEST isoform 2 in human placenta.
McMinn J; Wei M; Sadovsky Y; Thaker HM; Tycko B
Placenta; 2006; 27(2-3):119-26. PubMed ID: 16338457
[TBL] [Abstract][Full Text] [Related]
12. Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancer.
Pedersen IS; Dervan P; McGoldrick A; Harrison M; Ponchel F; Speirs V; Isaacs JD; Gorey T; McCann A
Hum Mol Genet; 2002 Jun; 11(12):1449-53. PubMed ID: 12023987
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma.
Kohda M; Hoshiya H; Katoh M; Tanaka I; Masuda R; Takemura T; Fujiwara M; Oshimura M
Mol Carcinog; 2001 Aug; 31(4):184-91. PubMed ID: 11536368
[TBL] [Abstract][Full Text] [Related]
14. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
15. No evidence of PEG1/MEST gene mutations in Silver-Russell syndrome patients.
Kobayashi S; Uemura H; Kohda T; Nagai T; Chinen Y; Naritomi K; Kinoshita EI; Ohashi H; Imaizumi K; Tsukahara M; Sugio Y; Tonoki H; Kishino T; Tanaka T; Yamada M; Tsutsumi O; Niikawa N; Kaneko-Ishino T; Ishino F
Am J Med Genet; 2001 Dec; 104(3):225-31. PubMed ID: 11754049
[TBL] [Abstract][Full Text] [Related]
16. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
17. Evidence against a major role of PEG1/MEST in Silver-Russell syndrome.
Riesewijk AM; Blagitko N; Schinzel AA; Hu L; Schulz U; Hamel BC; Ropers HH; Kalscheuer VM
Eur J Hum Genet; 1998; 6(2):114-20. PubMed ID: 9781054
[TBL] [Abstract][Full Text] [Related]
18. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of the RUNX3 gene in lung cancer.
Sato K; Tomizawa Y; Iijima H; Saito R; Ishizuka T; Nakajima T; Mori M
Oncol Rep; 2006 Jan; 15(1):129-35. PubMed ID: 16328045
[TBL] [Abstract][Full Text] [Related]
20. Use of real-time RT-PCR for the detection of allelic expression of an imprinted gene.
Suda T; Katoh M; Hiratsuka M; Fujiwara M; Irizawa Y; Oshimura M
Int J Mol Med; 2003 Aug; 12(2):243-6. PubMed ID: 12851725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
